22nd Jun 2021 10:57
Renalytix AI plc
("Renalytix" or the "Company")
Director/PDMR Dealing
The Company was informed that today, Christopher Mills, a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 113.5 pence per share.
Following completion of the sale, Christopher Mills is interested in 9,180,501 Ordinary Shares representing 12.74% of the current issued share capital of the Company.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Christopher Mills, non-exec director and Interim Chair of the issuer and director of NASCIT and Oryx International Growth Fund Ltd | |||
b)
| Initial notification /Amendment
| Initial Notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Renalytix AI plc | |||
b)
| LEI
| 213800NTOH3FK3WER551 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.0025 each | |||
|
| ||||
Identification code | GB00BYWL4Y04
| ||||
|
| ||||
b)
| Nature of the transaction
| Sale of shares | |||
c) | Currency | GBP | |||
d)
| Price(s) and volume(s) |
|
|
|
|
|
| Price(s) | Volume(s) |
| |
|
| 11.352941 | 17,000 |
| |
|
|
|
|
| |
e)
| Aggregated information |
| |||
|
| ||||
- Aggregated volume | 17,000 | ||||
|
| ||||
- Price | £192,999.99 | ||||
|
| ||||
f)
| Date of the transaction
| 18 June 2021 | |||
g)
| Place of the transaction
| London Stock Exchange | |||
Related Shares:
Renalytix Plc